David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.38% |
| 2 | Energy | 10.34% |
| 3 | Technology | 9.79% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Entegris
ENTG
$22.1B
| $1.53M | ﹤0.01% |
111,670
-78,598
| -41% | -$1.04M |
|
|
PBPB
2202
DELISTED
Potbelly
PBPB
| $1.53M | ﹤0.01% |
111,472
-58,985
| -35% | -$819K |
|
2203
Belden
BDC
$4.65B
| $1.52M | ﹤0.01% |
16,293
-2,698
| -14% | -$232K |
|
2204
CALL
Johnson Controls International
JCI
$86.6B
| $1.52M | ﹤0.01% |
28,841
-40,396
| -58% | -$2.05M |
|
|
PMCS
2205
DELISTED
P M C SIERRA INC
PMCS
| $1.52M | ﹤0.01% |
163,749
+78,868
| +93% | +$727K |
|
2206
Adtran
ADTN
$629M
| $1.52M | ﹤0.01% |
81,258
-48,296
| -37% | -$1.03M |
|
|
ATCO
2207
DELISTED
Atlas Corp.
ATCO
| $1.52M | ﹤0.01% |
83,160
-3,541
| -4% | -$64.8K |
|
2208
Open Text
OTEX
$6.08B
| $1.52M | ﹤0.01% |
57,386
-121,036
| -68% | -$3.46M |
|
|
CAI
2209
DELISTED
CAI International, Inc.
CAI
| $1.52M | ﹤0.01% |
61,693
+29,192
| +90% | +$675K |
|
2210
Bruker
BRKR
$8.96B
| $1.51M | ﹤0.01% |
81,801
-62,110
| -43% | -$1.18M |
|
|
CEB
2211
DELISTED
CEB Inc.
CEB
| $1.51M | ﹤0.01% |
18,900
+12,712
| +205% | +$957K |
|
2212
SK Telecom
SKM
$15.2B
| $1.51M | ﹤0.01% |
+33,602
| New | +$1.56M |
|
2213
CALL
Terex
TEX
$7.41B
| $1.5M | ﹤0.01% |
56,600
-7,600
| -12% | -$192K |
|
|
AFFX
2214
DELISTED
Affymetrix Inc
AFFX
| $1.5M | ﹤0.01% |
+119,715
| New | +$1.39M |
|
|
GDP
2215
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
| $1.5M | ﹤0.01% |
423,240
+263,270
| +165% | +$873K |
|
2216
EPAM Systems
EPAM
$5.9B
| $1.5M | ﹤0.01% |
24,463
+18,885
| +339% | +$1.03M |
|
2217
First Financial Bankshares
FFIN
$4.76B
| $1.5M | ﹤0.01% |
+108,404
| New | +$1.44M |
|
2218
CALL
Timken Company
TKR
$8.62B
| $1.49M | ﹤0.01% |
35,400
-5,700
| -14% | -$236K |
|
2219
Glacier Bancorp
GBCI
$6.11B
| $1.49M | ﹤0.01% |
59,199
-18,763
| -24% | -$465K |
|
2220
PUT
Golar LNG
GLNG
$5.25B
| $1.49M | ﹤0.01% |
44,700
-60,000
| -57% | -$1.92M |
|
|
BWLD
2221
PUT
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $1.49M | ﹤0.01% |
8,200
-190,800
| -96% | -$35.4M |
|
2222
CALL
Tenet Healthcare
THC
$21.7B
| $1.49M | ﹤0.01% |
30,000
| – | – |
|
2223
Mattel
MAT
$4.28B
| $1.48M | ﹤0.01% |
64,885
+39,535
| +156% | +$1.05M |
|
|
SYKE
2224
DELISTED
SYKES Enterprises Inc
SYKE
| $1.48M | ﹤0.01% |
59,661
-27,017
| -31% | -$635K |
|
2225
CAE Inc
CAE
$8.07B
| $1.48M | ﹤0.01% |
+126,769
| New | +$1.55M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $2.47B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 36% a quarter earlier, followed by Energy and Technology.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.